Pharmacogenomics Reporter GenomeWeb News Premium Content Existing subscribers login here. New to Pharmacogenomics Reporter? For a trial subscription click here.

Will HPCGG’s New Algorithm Spur Market
Adoption of PGx-Based Warfarin Dosing?

[December 5, 2007]

By Turna Ray

HPCGG and the FDA are working together to perfect a dosing algorithm for PGx-guided warfarin dosing with hopes of easing payor and physician reluctance to adopt genetics-based dosing decisions in mainstream practice.

Login | Subscribe